Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study.

Yoh Watanabe(Kanazawa University), Kazunori Ochiai(Juntendo University), Naotake Tanaka, Toru Nakanishi(Tohoku Medical and Pharmaceutical University Hospital), Masayuki Hatae(Kagoshima City Hospital), Keiichi Isaka, Hiroshi Hoshiai(Kindai University), Naoki Kawamura, Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Shoji Kamiura(Osaka International Cancer Institute)
PubMed
September 1, 2011
Cited by 8

Related Papers

A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
|New England Journal of Medicine|2004|839
Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209